Analyst Research

Report Title Price
Provider: GlobalData
Provider: Thomson Reuters Stock Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dainippon Sumitomo Pharma Co Ltd Raises Consolidated Full-year Outlook for FY 2014

Wednesday, 30 Oct 2013 02:00am EDT 

Dainippon Sumitomo Pharma Co Ltd announced that it has raised its consolidated full-year outlook for revenue from JPY 369,000 million to JPY 381,000 million, operating profit from JPY 26,000 million to JPY 35,000 million, ordinary profit from JPY 25,000 million to JPY 34,000 million, net profit from JPY 13,000 million to JPY 17,000 million and earning per share from JPY 32.72 to JPY 42.79, for the fiscal year ending March 2014. This is due to the increased sales, the record of extraordinary profit on selling of investment securities, among others. 

Company Quote

1.0 +0.08%
1:00am EST